Compare RLAY & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | ATRO |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | N/A | 2700 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2020 | N/A |
| Metric | RLAY | ATRO |
|---|---|---|
| Price | $12.79 | $71.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $19.50 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 3.6M | 350.5K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $14.92 |
| Revenue Next Year | $324.03 | $8.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $2.71 | $23.25 |
| 52 Week High | $17.32 | $83.96 |
| Indicator | RLAY | ATRO |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 48.19 |
| Support Level | $6.67 | $70.72 |
| Resistance Level | $17.32 | $79.86 |
| Average True Range (ATR) | 1.05 | 3.45 |
| MACD | -0.54 | -0.52 |
| Stochastic Oscillator | 9.98 | 39.78 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.